Literature DB >> 11698424

Leukocyte receptor complex-encoded immunomodulatory receptors show differing specificity for alternative HLA-B27 structures.

R L Allen1, T Raine, A Haude, J Trowsdale, M J Wilson.   

Abstract

We studied recognition of the disease-associated HLA-B27 allele by immunomodulatory receptors encoded within the leukocyte receptor complex. HLA class I are ligands for members of the killer Ig receptor (KIR) and Ig-like transcript (ILT)/LIR/LILR families (the new LILR nomenclature is described at www. gene.ucl.ac.uk/nomenclature/genefamily/lilr.html). Members of these families bound HLA-B27 in both classical and beta(2) microglobulin-independent forms. Classical complexes bound ILT2, ILT4, and LIR6 transfectants but not ILT1, ILT3, or ILT5. A free H chain form of HLA-B27 bound ILT4 and LIR6. Both forms of HLA-B27 bound KIR3DL1 transfectants. HLA-B27 free H chain bound CD14(+) cells in PBL from healthy controls, consistent with ILT4 expression on monocytes. Alternative recognition of different forms of HLA-B27 by KIR or ILT could influence their immunomodulatory function and may imply a role in inflammatory disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11698424     DOI: 10.4049/jimmunol.167.10.5543

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  47 in total

Review 1.  Endoplasmic reticulum aminopeptidases: Biology and pathogenic potential.

Authors:  Nigil Haroon; Robert D Inman
Journal:  Nat Rev Rheumatol       Date:  2010-06-08       Impact factor: 20.543

Review 2.  HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations.

Authors:  Inés Colmegna; Raquel Cuchacovich; Luis R Espinoza
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

Review 3.  The multi-faceted nature of HLA class I dimer molecules.

Authors:  Elaine C Campbell; Antony N Antoniou; Simon J Powis
Journal:  Immunology       Date:  2012-08       Impact factor: 7.397

Review 4.  Natural killer cells and their receptors in multiple sclerosis.

Authors:  Gurman Kaur; John Trowsdale; Lars Fugger
Journal:  Brain       Date:  2012-06-25       Impact factor: 13.501

Review 5.  LILRB receptor-mediated regulation of myeloid cell maturation and function.

Authors:  William van der Touw; Hui-Ming Chen; Ping-Ying Pan; Shu-Hsia Chen
Journal:  Cancer Immunol Immunother       Date:  2017-06-21       Impact factor: 6.968

6.  HLA-B27 homodimers and free H chains are stronger ligands for leukocyte Ig-like receptor B2 than classical HLA class I.

Authors:  Joanna Giles; Jackie Shaw; Christopher Piper; Isabel Wong-Baeza; Kirsty McHugh; Anna Ridley; Demin Li; Izabela Lenart; Antony N Antoniou; Katilin DiGleria; Kimiko Kuroki; Katsumi Maenaka; Paul Bowness; Simon Kollnberger
Journal:  J Immunol       Date:  2012-05-16       Impact factor: 5.422

Review 7.  Functional and genetic diversity of leukocyte immunoglobulin-like receptor and implication for disease associations.

Authors:  Kouyuki Hirayasu; Hisashi Arase
Journal:  J Hum Genet       Date:  2015-06-04       Impact factor: 3.172

8.  Genome-wide gene expression profiling reveals unsuspected molecular alterations in pemphigus foliaceus.

Authors:  Danielle Malheiros; Rodrigo A Panepucci; Ana M Roselino; Amélia G Araújo; Marco A Zago; Maria Luiza Petzl-Erler
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

9.  Diversity of the human LILRB3/A6 locus encoding a myeloid inhibitory and activating receptor pair.

Authors:  Arman A Bashirova; Richard Apps; Nicolas Vince; Yelizaveta Mochalova; Xu G Yu; Mary Carrington
Journal:  Immunogenetics       Date:  2013-10-06       Impact factor: 2.846

10.  Microbially cleaved immunoglobulins are sensed by the innate immune receptor LILRA2.

Authors:  Kouyuki Hirayasu; Fumiji Saito; Tadahiro Suenaga; Kyoko Shida; Noriko Arase; Keita Oikawa; Toshifumi Yamaoka; Hiroyuki Murota; Hiroji Chibana; Ichiro Nakagawa; Tomoko Kubori; Hiroki Nagai; Yuji Nakamaru; Ichiro Katayama; Marco Colonna; Hisashi Arase
Journal:  Nat Microbiol       Date:  2016-04-25       Impact factor: 17.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.